SkinBioTherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2016
Period Ending	Sep '24 Sep 9, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2018 - 2016
Market Capitalization	27	22	32	100	22	26	Upgrade
Market Cap Growth	8.17%	-31.83%	-68.11%	353.88%	-14.38%	51.44%	Upgrade
Enterprise Value	24	21	29	94	19	23	Upgrade
Last Close Price	0.12	0.13	0.20	0.64	0.17	0.20	Upgrade
PE Ratio	-	-7.26	-11.37	-65.01	-14.58	-21.21	Upgrade
PS Ratio	128.52	163.89	424.66	-	-	-	Upgrade
PB Ratio	6.19	10.85	12.83	19.09	8.90	6.72	Upgrade
P/FCF Ratio	-9.30	-7.91	-11.88	-64.02	-24.59	-17.80	Upgrade
P/OCF Ratio	-9.62	-8.18	-11.88	-64.02	-24.59	-17.93	Upgrade
EV/Sales Ratio	149.12	158.92	384.18	-	-	-	Upgrade
EV/EBITDA Ratio	-9.28	-7.02	-9.63	-62.91	-12.04	-17.02	Upgrade
EV/EBIT Ratio	-9.17	-7.00	-9.63	-62.84	-12.01	-16.98	Upgrade
EV/FCF Ratio	-7.72	-7.67	-10.75	-60.50	-21.80	-16.05	Upgrade
Debt / Equity Ratio	0.03	0.05	0.05	0.03	-	-	Upgrade
Debt / FCF Ratio	-0.03	-0.04	-0.05	-0.09	-	-	Upgrade
Asset Turnover	0.05	0.05	0.02	-	-	-	Upgrade
Inventory Turnover	0.89	0.60	-	-	-	-	Upgrade
Quick Ratio	6.48	3.05	4.19	11.91	7.55	28.11	Upgrade
Current Ratio	6.57	3.25	4.58	12.50	7.70	29.49	Upgrade
Return on Equity (ROE)	-118.64%	-126.84%	-72.62%	-37.31%	-47.80%	-31.67%	Upgrade
Return on Assets (ROA)	-61.18%	-66.02%	-42.26%	-22.00%	-30.21%	-22.43%	Upgrade
Return on Capital (ROIC)	-74.81%	-79.79%	-46.84%	-23.93%	-32.27%	-23.45%	Upgrade
Earnings Yield	-13.90%	-13.10%	-8.80%	-1.44%	-6.84%	-4.48%	Upgrade
FCF Yield	-11.63%	-12.64%	-8.42%	-1.56%	-4.07%	-5.62%	Upgrade
Buyback Yield / Dilution	-11.47%	-5.06%	-6.87%	-14.53%	-4.95%	-2.81%	Upgrade
Total Shareholder Return	-11.47%	-5.06%	-6.87%	-14.53%	-4.95%	-2.81%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.